tiprankstipranks
Strategic Resilience and Growth Potential: A Buy Rating for PTC Therapeutics Amid Regulatory Challenges
PremiumRatingsStrategic Resilience and Growth Potential: A Buy Rating for PTC Therapeutics Amid Regulatory Challenges
6d ago
PTC Therapeutics: Strategic Growth and Market Expansion Justify Buy Rating Amid Regulatory Challenges
Premium
Ratings
PTC Therapeutics: Strategic Growth and Market Expansion Justify Buy Rating Amid Regulatory Challenges
7d ago
PTC Therapeutics Faces EU Setback on Translarna
Premium
Company Announcements
PTC Therapeutics Faces EU Setback on Translarna
7d ago
PTC Therapeutics price target raised to $50 from $46 at Citi
PremiumThe FlyPTC Therapeutics price target raised to $50 from $46 at Citi
22d ago
PTC Therapeutics upgraded to Neutral from Underperform at BofA
Premium
The Fly
PTC Therapeutics upgraded to Neutral from Underperform at BofA
25d ago
Tesla upgraded, Coinbase initiated: Wall Street’s top analyst calls
Premium
The Fly
Tesla upgraded, Coinbase initiated: Wall Street’s top analyst calls
28d ago
PTC Therapeutics Faces Regulatory and Revenue Challenges: Analyst Maintains Sell Rating
PremiumRatingsPTC Therapeutics Faces Regulatory and Revenue Challenges: Analyst Maintains Sell Rating
1M ago
PTC Therapeutics: Buy Rating Backed by Promising Clinical Catalysts and Solid Commercial Foundation
Premium
Ratings
PTC Therapeutics: Buy Rating Backed by Promising Clinical Catalysts and Solid Commercial Foundation
1M ago
PTC Therapeutics price target lowered to $72 from $74 at JPMorgan
Premium
The Fly
PTC Therapeutics price target lowered to $72 from $74 at JPMorgan
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100